The global enteral feeding formulas market revenue was around US$ 6.7 billion in 2023 and is estimated to reach US$ 12.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2024 to 2032.

Enteral feeding formulas called enteral nutrition or tube feeding formulas, are specialized liquid nutrition solutions developed to deliver vital calories and nutrients to individuals who are incapable of consuming food orally due to surgery, medical situations, or other factors.

Factors Influencing Market Growth

- The enteral feeding formula market is anticipated to grow significantly, because of the surge in the prevalence of chronic diseases like strokes, neurological disorders, and cancer, the increase in the geriatric population, and the rise in the incidence of preterm births.

- The low patient compliance poses a substantial challenge for the enteral feeding formula market.

- The aging procedure itself can bring about physiological differences that make it more difficult for older adults to absorb vital nutrients from food. This makes enteral feeding formulas a valuable resource for fulfilling their nutritional requirements efficiently and effectively. Therefore, the increase in geriatric population is anticipated to propel the growth of the market.

Impact of COVID-19

The COVID-19 pandemic has rapidly augmented cases, resulting in a surge in ICU entries due to extreme chronic health conditions and coronavirus infections. It has led to the expanded adoption of enteral nutrition, propelling the growth of the enteral feeding formulas market. During the COVID-19 pandemic, the adoption of enteral feeding formulas was augmented due to guidelines published by healthcare authorities.

Regional Analysis

In 2023, Europe dominated the global enteral feeding formulas market in terms of revenue because of the surge in the prevalence of chronic conditions well-developed healthcare infrastructure, and the rise in the prevalence of cancer.

Also, Asia-Pacific is anticipated to show the fastest growth during the forecast period, with an increase in the several geriatric patients and a surge in the incidence of preterm births.

Leading Companies

The leading prominent companies profiled in the global enteral feeding formulas market are: -

- Abbott Laboratories
- Nestl?
- Danone S.A
- Fresenius SE and Co. KGaA
- B. Braun SE
- Otsuka Holdings
- Nutritional Medicinals, LLC
- Kate Farms
- Global Health Products Inc
- DermaRite Industries, LLC
- Other prominent key players

Segmentation Outline

The global enteral feeding formulas market segmentation focuses on Product Type, Age Group, Application, End user, and Region.

Segmentation based on Product Type

- Standard Formulas
- Disease-specific Formulas
- Peptide-Based
- Immune modulating
- Blenderized

Segmentation based on Age Group

- Adult
- Child

Segmentation based on Application

- Cancer
- Neurological Disorders
- Gastrointestinal Disorders
- Malnutrition
- Others

Segmentation based on End user

- Hospital
- Long-term Care Facilities
- Others

Segmentation based on Region

- North America
- The U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa